Events & Presentations
Upcoming Events
| Date | Event Details | Remind Me |
|---|---|---|
|
Aug 5, 2021 4:30 PM EDT
|
Arrowhead Pharmaceuticals 2021 Third Quarter Results
|
Archived Events
| Date | Event Details |
|---|---|
|
Sep 16, 2019 11:00 AM +04
|
Global Summit On Cardiology & Heart Diseases
View Presentation 5.6 MB
Dubai, UAE
Bruce Given, M.D., Arrowhead’s chief operating officer and head of R&D, will deliver a keynote presentation titled, “Treating hypertriglyceridemic states with RNA interference – emergence of an exciting new modality to treat cardiovascular diseases”
|
|
Sep 16, 2019
|
Developing Alpha-1 Antitrypsin Therapeutics; FDA Public Workshop
View Presentation 7.1 MB
Bethesda, MD
|
|
Sep 14, 2019
|
Alpha-1 UK Support Group Event 2019
View Presentation 5 MB
Daventry, Northamptonshire, UK
|
|
Sep 5, 2019
|
Citi’s 14th Annual Biotech Conference
Boston, MA
|
|
Sep 4, 2019 9:40 AM EDT
|
Baird's 2019 Global Healthcare Conference
New York, NY
|
|
Aug 12, 2019
|
BTIG Biotechnology Conference 2019
New York, NY
|
|
Aug 5, 2019 4:30 PM EDT
|
Arrowhead Pharmaceuticals 2019 Third Quarter Results
Prepared Remarks 181.4 KB
|
|
Jul 17, 2019
|
Roth RNA Revolution Conference
Bruce Given, M.D., Arrowhead’s chief operating officer and head of R&D, and Vincent Anzalone, CFA, Arrowhead’s vice president of investor relations, will participate in panel discussions.
|
|
Jun 21, 2019
|
Alpha-1 National Conference
View Presentation 8.8 MB
Orlando, FL
James Hamilton, M.D., Arrowhead’s vice president of clinical development, will deliver an oral presentation titled, “ARO-AAT for Liver Disease in Alpha-1 Antitrypsin Deficiency: Progress in Clinical Development”
|
|
Jun 8, 2019 2:30 PM +08
|
Science of HBV Cure 2019
View Presentation 2.8 MB
Singapore
Bruce Give, M.D., Arrowhead’s chief operating officer and head of R&D, will deliver an oral presentation titled, “RNAi: Pulling Us Toward Finite Therapy”
|